Looking At Pfizer's Recent Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant amount of unusual options activity has been observed for Pfizer (NYSE:PFE), with a majority of investors taking a bearish stance. The targeted price range for Pfizer over the last 3 months has been $25.0 to $35.0. The current price of PFE is $30.58, up 0.07%. Analysts from Morgan Stanley, JP Morgan, Truist Securities, BMO Capital, and UBS have maintained their ratings on Pfizer, with price targets ranging from $33 to $42.
November 01, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pfizer has seen unusual options activity, with a bearish sentiment among investors. Analysts have maintained their ratings, with price targets ranging from $33 to $42.
The bearish sentiment observed in Pfizer's options activity indicates that investors expect the stock price to decrease. This, combined with the fact that the current price of PFE is near the lower end of the targeted price range, suggests a potential negative short-term impact on the stock. However, the maintained ratings from analysts could provide some stability.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100